Literature DB >> 10675110

Response of metastatic breast cancer to trastuzumab?

D M Barnes1, D W Miles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10675110     DOI： 10.1016/S0140-6736(99)00430-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Recent advances in anti-angiogenic therapy of cancer.

Authors:  Rajeev S Samant; Lalita A Shevde
Journal:  Oncotarget       Date:  2011-03

Review 2.  Whither high-dose chemotherapy in breast cancer?

Authors:  A Mayer; H Earl
Journal:  Breast Cancer Res       Date:  2000-11-08       Impact factor: 6.466

3.  EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: implications for targeted radiotherapy.

Authors:  Li Shen; Yongjie Shui; Xiaojia Wang; Liming Sheng; Zhengyan Yang; Danfeng Xue; Qichun Wei
Journal:  BMC Cancer       Date:  2008-08-12       Impact factor: 4.430

Review 4.  Therapeutic applications of monoclonal antibodies.

Authors:  Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.